Back to search

Article

Clinical Outcome and Prognosis of Differentiated Thyroid Carcinoma with Distant Metastasis

2024-09-08

Abstract excerpt

<title>Abstract</title> <p>Objective To investigate the risk and prognostic factors of Radioactive iodide (RAI)-refractory (RAIR) in distant metastatic (DM) differentiated thyroid cancer (DTC). Methods DM-DTC patients who received iodine-131 radiation therapy were enrolled in this cohort study. After exclusion, 75 DTC radioiodine therapy resistant patients and 53 treatment effective patients were finally includ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf9e2993-0dd9-5519-91cf-43ff742c8fb9
DOI
10.21203/rs.3.rs-4839819/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Outcome and Prognosis of Differentiated Thyroid Carcinoma with Distant MetastasisDOI 10.21203/rs.3.rs-4839819/v1
Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer.Semantic proximity
Effect of BRAFV600E and TERT Promoter Mutations on Thyroglobulin Response in Patients With Distant-Metastatic Differentiated Thyroid Cancer.Semantic proximity
TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.Semantic proximity
Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology.Semantic proximity
Association between clinical and pathological factors and risk of radioiodine refractory in patients with differentiated thyroid carcinoma.Semantic proximity
The Correlation Between the Presence of BRAFV600E and TERT Promoter Mutation and the Response to Treatment with Iodine 131 in Differentiated Thyroid Cancer Patients.Semantic proximity
Efficacy of Radioiodine in Non-Distant Metastatic Papillary Thyroid Cancer with TERT-p Mutation at Initial DiagnosisSemantic proximity
Risk and Outcome of Secondary Primary Malignancies After Radioactive Iodine Treatment in Differentiated Thyroid Cancer PatientsSemantic proximity
TERT Promoter Mutations Contribute to Adverse Clinical Outcomes and Poor Prognosis in Radioiodine Refractory Differentiated Thyroid CancerSemantic proximity
Risk of second primary malignancy after radioiodine for thyroid carcinoma: a SEER-based studySemantic proximity
Risk Stratification Using a Novel Genetic Classifier Including PLEKHS1 Promoter Mutations for Differentiated Thyroid Cancer with Distant Metastasis.Semantic proximity
Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.Semantic proximity
Select a neighboring publication to make it the new centre.